Viral Oncology
eBook - ePub

Viral Oncology

New Approaches to Molecular Cancer Therapeutics

  1. 512 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Viral Oncology

New Approaches to Molecular Cancer Therapeutics

About this book

Viral Oncology: New Approaches to Molecular Cancer Therapeutics offers a comprehensive exploration of how viruses contribute to cancer development, bridging the gap between basic virology and clinical oncology. Featuring contributions from leading researchers, this authoritative text examines the mechanisms of viral oncogenesis, key oncogenic viruses, and the latest therapeutic strategies. The book highlights cutting-edge research on Human Papillomavirus (HPV), Epstein-Barr Virus (EBV), Hepatitis B and C, and other cancer-causing viruses, providing clinicians and researchers with critical insights into the prevention, diagnosis, and treatment of virus-induced cancers.

Ideal for oncologists, virologists, and molecular biologists, this text equips readers with both foundational knowledge and the latest advancements in the rapidly evolving field of viral oncology. Stay ahead in the field with this definitive guide to understanding and combating virusinduced malignancies. The volume explores the biology and pathology of oncogenic viruses, offering insights into novel therapeutic approaches, including immunotherapy and gene editing.

Viral Oncology: New Approaches to Molecular Cancer Therapeutics presents an in-depth and authoritative examination of how oncogenic viruses contribute to cancer development and progression, bridging the critical gap between foundational virology and clinical oncology. This volume brings together groundbreaking research from world-renowned scientists and clinicians who explore the complex mechanisms of viral oncogenesis, shedding light on both well-established and emerging viral agents, such as HPV, EBV, Hepatitis B and C, and Kaposi's Sarcoma-associated Herpesvirus (KSHV).

The text delves into the molecular processes through which these viruses initiate and sustain cancerous growth, offering insights into viral integration, immune evasion, and cellular transformation. With a focus on the latest developments in therapeutic strategies, Viral Oncology covers innovative approaches, including targeted molecular therapies, immunotherapies, gene editing techniques, and personalized medicine strategies aimed at halting virus-induced tumorigenesis.

Designed for a broad audience of oncologists, virologists, molecular biologists, and clinical researchers, this text provides a thorough understanding of the epidemiology, pathology, and treatment implications of viral oncology. It serves as an indispensable guide to the mechanisms of virus-driven cancers and how these insights are being translated into cutting-edge therapeutic interventions.

With its rich blend of cutting-edge science, clinical applications, and visionary outlook, Viral Oncology: New Approaches to Molecular Cancer Therapeutics is an essential resource for any professional involved in cancer research, diagnostics, and treatment. Whether you are a seasoned oncologist, virologist, or a researcher investigating the molecular basis of cancer, this book offers the latest knowledge and tools to effectively understand and combat virus-induced malignancies. Stay at the forefront of the rapidly evolving field of viral oncology with this comprehensive and forward-looking text – a definitive resource for understanding the interplay between viruses and cancer, and harnessing that knowledge for therapeutic innovation.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Viral Oncology by Umesh Kumar,Deepak Parashar,Subodh Kumar in PDF and/or ePUB format, as well as other popular books in Medicine & Oncology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2025
eBook ISBN
9781040329580
Edition
0
Subtopic
Oncology

Table of contents

  1. Cover
  2. Half-Title Page
  3. Series Page
  4. Title Page
  5. Copyright Page
  6. Dedication
  7. Table of Contents
  8. Preface
  9. Acknowledgements
  10. About the Editors
  11. List of Contributors
  12. 1 Past, Present, and Future of Emerging Oncogenic Viral Infections
  13. 2 Global Epidemiology of Oncogenic Viral Infections
  14. 3 Host–Viral Interactions during Oncogenic Infections
  15. 4 Types of Viral Oncogenic Viral Diseases
  16. 5 Genetic Factors Influencing Oncogenic Viral Disease
  17. 6 Immune Response Associated with Oncogenic Viral Diseases
  18. 7 Immune Evasion Strategies by Oncogenic Viral Infections
  19. 8 Co-Infections Associated with Oncogenic Viral Disease
  20. 9 Oncogenic Viruses-Encoded microRNAs in Hepatotropic Oncogenic Viral Diseases
  21. 10 Hepatitis B Virus Infection: Epidemiology, Transmission, and Prevention
  22. 11 Cytomegalovirus (CMV): Diagnosis and Treatment
  23. 12 Causes, Symptoms, and Treatment of Epstein–Barr Virus Infection
  24. 13 Difficulties in Promptly Diagnosing and Treating Neonatal Herpes Simplex Virus Infection
  25. 14 Detection Methods in HPV-Related Cancers: Pathways and Targeted Therapeutic Strategies
  26. 15 Human T-Cell Leukemia Virus (HTLV)-Induced Carcinogenesis and Its Molecular Detection
  27. 16 Merkel cell Polyomavirus: Oncogenic Potential, Diagnosis, and Treatment
  28. 17 Developing New Molecular-Targeted Therapeutics, ā€˜from Gene to Drug’
  29. 18 The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
  30. 19 Malignant Transformation In Vitro by Oncogenic Viruses
  31. 20 Laboratory Animal Model for Oncogenic Virus
  32. 21 Advances in Immunobiological Agents against Oncogenic Viral Diseases
  33. 22 CAR T-Cell Therapies against Viral Oncogenesis
  34. 23 miRNA-Associated Therapies for Oncogenic Viral Diseases
  35. 24 Vaccines: Future Prospects for Oncogenic Viral Diseases
  36. 25 Molecular Cancer Drug Discovery: Creative Interaction between Chemistry and Biology
  37. 26 Challenges and Future Perspectives of Using Antivirals in Viral Oncogenesis
  38. 27 Prevention and Therapeutic Approaches for Oncogenic Infections
  39. 28 Mesenchymal Stem Cells as Ideal Candidate for Delivering Oncolytic Viruses in the Tumour Microenvironment to Target Cancer Stem Cells
  40. 29 Viral Infections and Graft versus Host Disease Impeding Clinical Relevance of Hematopoietic Stem Cell Transplantation
  41. Index